| SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT |
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
| |
|
Healthcare IT |
|
|
Medical
Practice
Management
|
|
|
Unallocated Corporate
Expenses
|
|
|
Total |
|
| |
|
Three Months Ended March 31, 2024 |
|
| |
|
($ in thousands) |
|
| |
|
Healthcare IT |
|
|
Medical
Practice
Management
|
|
|
Unallocated Corporate
Expenses
|
|
|
Total |
|
| Net revenue |
|
$ |
22,721 |
|
|
$ |
3,241 |
|
|
$ |
- |
|
|
$ |
25,962 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Direct operating costs |
|
|
12,544 |
|
|
|
2,633 |
|
|
|
- |
|
|
|
15,177 |
|
| Selling and marketing |
|
|
1,760 |
|
|
|
10 |
|
|
|
- |
|
|
|
1,770 |
|
| General and administrative |
|
|
2,581 |
|
|
|
434 |
|
|
|
706 |
|
|
|
3,721 |
|
| Research and development |
|
|
913 |
|
|
|
- |
|
|
|
- |
|
|
|
913 |
|
| Depreciation and amortization |
|
|
3,845 |
|
|
|
85 |
|
|
|
- |
|
|
|
3,930 |
|
| Loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
322 |
|
|
|
- |
|
|
|
- |
|
|
|
322 |
|
| Net loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
322 |
|
|
|
- |
|
|
|
- |
|
|
|
322 |
|
| Total operating expenses |
|
|
21,965 |
|
|
|
3,162 |
|
|
|
706 |
|
|
|
25,833 |
|
| Operating income (loss) |
|
$ |
756 |
|
|
$ |
79 |
|
|
$ |
(706 |
) |
|
$ |
129 |
|
| |
|
Healthcare IT |
|
|
Medical Practice
Management
|
|
|
Unallocated Corporate
Expenses
|
|
|
Total |
|
| |
|
Three Months Ended March 31, 2023 |
|
| |
|
($ in thousands) |
|
| |
|
Healthcare IT |
|
|
Medical Practice
Management
|
|
|
Unallocated Corporate
Expenses
|
|
|
Total |
|
| Net revenue |
|
$ |
26,954 |
|
|
$ |
3,047 |
|
|
$ |
- |
|
|
$ |
30,001 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Direct operating costs |
|
|
15,693 |
|
|
|
2,414 |
|
|
|
- |
|
|
|
18,107 |
|
| Selling and marketing |
|
|
2,604 |
|
|
|
8 |
|
|
|
- |
|
|
|
2,612 |
|
| General and administrative |
|
|
2,496 |
|
|
|
448 |
|
|
|
2,176 |
|
|
|
5,120 |
|
| Research and development |
|
|
1,078 |
|
|
|
- |
|
|
|
- |
|
|
|
1,078 |
|
| Depreciation and amortization |
|
|
2,949 |
|
|
|
89 |
|
|
|
- |
|
|
|
3,038 |
|
| Net loss on lease terminations and unoccupied lease charges |
|
|
269 |
|
|
|
- |
|
|
|
- |
|
|
|
269 |
|
| Net loss on lease terminations, unoccupied lease charges and restructuring costs |
|
|
269 |
|
|
|
- |
|
|
|
- |
|
|
|
269 |
|
| Total operating expenses |
|
|
25,089 |
|
|
|
2,959 |
|
|
|
2,176 |
|
|
|
30,224 |
|
| Operating income (loss) |
|
$ |
1,865 |
|
|
$ |
88 |
|
|
$ |
(2,176 |
) |
|
$ |
(223 |
) |
|